Universal Screening May Help Identify High School Students At Risk For Suicide, Researchers Posit

Healio (2/2, Weldon) reports, “Universal screening helped identify high school students at risk for suicide and made them more likely to engage in mental health treatment,” researchers concluded in a study that “included 12,909 students in 14 high schools in Pennsylvania.” The findings were published in the December 2022 issue of the Journal of Pediatrics.

Related Links:

— “Universal screening helps identify adolescents at risk for suicide “Rose Weldon, Healio, February 2, 2023

Seniors who frequently take sleeping medications may be raising risk for dementia

HealthDay (2/1, Mozes) reports, “Seniors who frequently take sleeping medications may be raising their risk for developing” dementia, investigators concluded in a study that “enlisted roughly 3,000 seniors to share their sleep medication routines starting in 1997.” The study also revealed that “among white and Black participants, frequent usage was highest among women, those struggling with depression and the more highly educated.” Even though “white seniors who used sleeping pills frequently faced a 79% higher risk for dementia, that was not the case among Black seniors.” The findings were published online in the Journal of Alzheimer’s Disease.

Related Links:

— “Sleeping Pills Linked to Higher Risk for Dementia “Alan Mozes, HealthDay, February 1, 2023

COVID-19 Public Health Emergency Set To End May 11

According to Psychiatric News (2/1), on Jan. 30, “the Biden administration announced” (PDF) that “the COVID-19 Public Health Emergency (PHE), first issued in March 2020, will end on May 11.” The PHE “waived a host of restrictions on the use of telehealth to help patients receive services, including mental health services, without leaving their homes,” but “with the end of the emergency, those waivers will be lifted, and several pre-pandemic regulations will be back in effect.” However, “some states and health care plans…may continue certain flexibilities and coverage; commercial and Medicaid payers may vary widely in their telehealth policies.”

Related Links:

— “Biden Announces End of COVID Public Health Emergency in May, Psychiatric News, February 1, 2023

For Informal Caregivers Of Those Hospitalized For Mental Illness, Affiliated Stigma May Be A Full Mediator Between Their Role As Caregiver And Their Involvement With Patients, Researchers Posit

“The fear and lack of understanding of mental illness can lead to stigma. The stigma of mental illness affects not only individuals who suffer from it, but also the caregivers. Stigma among caregivers can lead to delay in seeking care, poor adherence to treatment and a high risk of relapse. Caregivers of patients with mental illness are at an increased risk of distress due to the burden to stigma and caregiving burden. An increase in caregivers’ burden can lead to a reduction in caregivers’ involvement. There is a relationship between caregivers’ involvement, burden, and affiliated stigma. The present study examined the mediating role of affiliated stigma in the relationship between caregivers’ burden and involvement among informal caregivers of hospital-admitted patients with mental illness in Uganda.” In a “cross-sectional study…conducted among 428 adult caregivers” of “individuals diagnosed with mental illness and admitted to the Mbarara Regional Referral Hospital’s psychiatry unit between July 2020 and November 2020.” The findings were published online Jan. 26 in BMC Psychiatry.

Related Links:

— “Involvement and burden of informal caregivers of patients with mental illness: the mediating role of affiliated stigma, BMC Psychiatry, January 26, 2023

Oral Vitamin D Supplementation Appears To Nearly Halve Rates Of Suicide, Intentional Self-Harm In US Veterans, Research Suggests

Medscape (2/1, Tucker, Subscription Publication) reports, “Oral vitamin D supplementation nearly halved the rates of suicide and intentional self-harm in a study of US veterans, with an even stronger effect among Black veterans,” investigators concluded in findings published online Feb. 1 in PLOS ONE. Additionally, “the retrospective cohort study,” which involved “about 490,885 veterans who received vitamin D3 (cholecalciferol) and 169,241 veterans who received vitamin D2 (ergocalciferol)” who “were compared one-on-one with veterans of similar demographics and medical histories who didn’t receive supplementation,” revealed that “higher daily vitamin D supplement dosages appeared to offer greater protection against suicide and self-harm risk than lower doses, that the effect was greater among those with baseline vitamin D deficiency or insufficiency, and that both” ergocalciferol and cholecalciferol “supplements were effective.”

Related Links:

Medscape (requires login and subscription)

Compared With Sustained Or Even Reduced Smoking Intensity, Smoking Cessation Appears Tied To Lower Risk For Dementia, Study Indicates

Healio (1/31, Downey) reports, “Smoking cessation was associated with lower risk for dementia, including Alzheimer’s disease and vascular dementia, compared with sustained or even reduced smoking intensity,” investigators concluded in a study that included 789,532 participants. The findings were published online in JAMA Network Open.

Related Links:

— “Smoking cessation, rather than reduction, linked to lower risk for dementia “Ken Downey Jr., Healio, January 31, 2023

For Individuals Prescribed Antipsychotic Medication, Nonadherence, Along With Switching And Stopping Medication, May Be Tied To Increases In Acute Care Utilization, Research Suggests

Healio (1/31, Herpen) reports, “For individuals prescribed antipsychotic medication, nonadherence, along with switching and stopping medication, was associated with increases in acute care utilization,” investigators concluded in a study that “included 577 individuals with schizophrenia, 795 with bipolar disorder and 618 who were prescribed antipsychotics but lacked a diagnosis of either illness.” The findings were published online Jan. 24 in BMC Psychiatry.

Related Links:

— “Nonadherence, switching, stopping antipsychotics linked to more acute care utilization “Robert Herpen, Healio, January 31, 2023

Substance Use Declined Among Teens But Was Inconsistent Among Adults During First Year Of Pandemic, Study Finds

CNN (1/31, LaMotte) reports that “use of marijuana and other substances dropped in teenagers during the first year of the pandemic,” but “adults’ use of cannabis, illegal drugs and alcohol, including binge drinking, either stayed the same or increased compared to the two years before COVID-19,” according to a study that “analyzed data from the Population Assessment of Tobacco and Health Study.” The researcher wrote, “Substance use decreased between 2019 and 2020 among those aged 13 to 20 years,” but “consistent declines were not seen in older persons other than tobacco use reductions, and cannabis use increased among adults ages 25 years and older.” The findings were published online in JAMA Network Open.

Related Links:

— “Adult drug use rose during pandemic, but dropped dramatically in youth, study says “Sandee LaMotte, CNN, January 31, 2023

High-intensity alcohol use among youth primarily occurs during high school

MedPage Today (1/30, Henderson) reports a study published in JAMA Pediatrics found that “most teen alcohol use that escalated to having 10 or more drinks in a row reached that level rapidly during the high school years.” In “a sample of youth who reported drinking in the prior 30 days when surveyed in the 12th grade and who said they engaged in high-intensity drinking (HID)…when surveyed again around age 20, initiation of all three levels of alcohol use – first drink, binging on five or more drinks in a row, and HID – primarily occurred during high school grades 9 to 12,” and “it happened fast,” according to researchers.

Related Links:

MedPage Today (requires login and subscription)

Many Adults With Epilepsy Also Have Agoraphobia, Study Indicates

HealthDay (1/30, Murez) reports that “many adults with epilepsy have agoraphobia, or a fear of public places,” according to a study that “used data from a neuropsychology registry study to analyze a diverse sample of 420 adults.” The lead study author explained, “More than one-third of the participants reported significant phobic/agoraphobic symptoms. … We also found that phobic/agoraphobic symptoms, along with depression symptoms, were independently associated with poor quality of life, but generalized anxiety symptoms were not.” The study findings were published online in Epilepsy Research.

Related Links:

— “Fear of Public Spaces Is Common in People With Epilepsy “Cara Murez, HealthDay, January 30, 2023